Biotest AG
ISIN: DE0005227235 | Ticker: BIO3
Biotest is a global company that supplies plasma protein products and biotherapeutic drugs. Our products are primarily used in the therapeutic areas of clinical immunology, haematology and intensive care medicine. For patients with serious and often chronic diseases they provide targeted treatment, which generally enable them to lead almost normal lives.
Within our areas of specialisation, we start from pre-clinical and clinical development to manufacturing and global marketing. Research, development and production are carried out at our main headquarters in Germany. Our own sales organisations (subsidiaries) and cooperating partners represent our global distribution network.
1946
Served areaWorldwide
Headcount1,663
HeadquartersLandsteinerstraße 5, 63303 Dreieich – Germany
| Date | Trading entity / Person | Association | Trade type | Volume | Average price |
|---|---|---|---|---|---|
| 29.11.21 | Bernöster, Dr. Katrin | Other | Sell | 15,640.00 € | 29.11.21 |
| 29.11.21 | Realsoul Holding S.A. | Close relation | Buy | 1,713.60 € | 29.11.21 |
| 18.11.21 | Moritz, Michael | Other | Sell | 35,460.00 € | 18.11.21 |
| 18.11.21 | Schüttrumpf, Dr. Jörg | Other | Sell | 99,895.50 € | 18.11.21 |
| 18.11.21 | Fleck, Stephan | Other | Sell | 120,870.00 € | 18.11.21 |
| 18.11.21 | Reinecke, Dr. Martin | Other | Sell | 37,715.00 € | 18.11.21 |
19,785,726
IPOJan. 1, 1987
Stock exchange(s)Frankfurt Stock Exchange